Publications by authors named "Ruth Foley"

Claim this Profile
A
Artificial Intelligence (AI)-Aided Structure Optimization for Enhanced Gene Delivery: The Effect of the Polymer Component Distribution (PCD).
Yinghao Li, Zhonglei He, Sigen A, Xianqing Wang, Zishan Li, Ruth Foley

ACS Appl Mater Interfaces· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Branch Unit Distribution Matters for Gene Delivery.
Yinghao Li, Zhonglei He, Xianqing Wang, Zishan Li, Melissa Johnson, Ruth Foley

ACS Macro Lett· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the Bottom-Up Growth of Anisotropic Gold Nanoparticles from Substrate-Bound Seeds in Microfluidic Reactors.
Gail A Vinnacombe-Willson, Joy K Lee, Naihao Chiang, Leonardo Scarabelli, Shouzheng Yue, Ruth Foley

ACS Appl Nano Mater· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delivering the CRISPR/Cas9 system for engineering gene therapies: Recent cargo and delivery approaches for clinical translation.
Ruth A Foley, Ruby A Sims, Emily C Duggan, Jessica K Olmedo, Rachel Ma

Front Bioeng Biotechnol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-viral delivery of CRISPR-Cas9 complexes for targeted gene editing via a polymer delivery system.
Jonathan O'Keeffe Ahern, Irene Lara-Sáez, Dezhong Zhou, Rodolfo Murillas, Jose Bonafont, Ruth Foley

Gene Ther· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of Key Genes Driving Tumor Associated Macrophage Migration and Polarization Based on Immune Fingerprints of Lung Adenocarcinoma.
Jing Wu, Jiawei Zhou, Qian Xu, Ruth Foley, Jianqiang Guo

Front Cell Dev Biol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reactive oxygen species (ROS): utilizing injectable antioxidative hydrogels and ROS-producing therapies to manage the double-edged sword.
Zhonglei He, Qian Xu, Ben Newland, Ruth Foley, Irene Lara-Sáez

J Mater Chem B· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Demodex and rosacea revisited.
Ellen M Moran, Ruth Foley, Frank C Powell

Clin Dermatol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical potential of gene-directed enzyme prodrug therapy to improve radiation therapy in prostate cancer patients.
Alice Vajda, Laure Marignol, Ruth Foley, Thomas H Lynch, Mark Lawler

Cancer Treat Rev· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment on "Androgen-hypersensitive preclinical model of prostate cancer" by Kawata et al.
Ruth Foley, Laure Marignol, John P Keane, Thomas H Lynch, Donal Hollywood

Prostate· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Androgen hypersensitivity in prostate cancer: molecular perspectives on androgen deprivation therapy strategies.
Ruth Foley, Laure Marignol, John P Keane, Thomas H Lynch, Donal Hollywood

Prostate· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The HIF-1alpha C1772T polymorphism may be associated with susceptibility to clinically localised prostate cancer but not with elevated expression of hypoxic biomarkers.
Ruth Foley, Laure Marignol, Arun Z Thomas, Ivor M Cullen, Antoinette S Perry

Cancer Biol Ther· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The emerging roles of DNA methylation in the clinical management of prostate cancer.
Antoinette S Perry, Ruth Foley, Karen Woodson, Mark Lawler

Endocr Relat Cancer· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular pathology of prostate cancer: the key to identifying new biomarkers of disease.
Ruth Foley, Donal Hollywood, Mark Lawler

Endocr Relat Cancer· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene-based therapy in prostate cancer.
Ruth Foley, Mark Lawler, Donal Hollywood

Lancet Oncol· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis